Stockscreener 앱 받기
95.75
4.00%
3.68
시간 외 거래:
95.75
전일 마감가:
$92.07
열려 있는:
$94.89
하루 거래량:
3.73M
Relative Volume:
1.55
시가총액:
$18.52B
수익:
$8.41B
순이익/손실:
$760.80M
주가수익비율:
24.86
EPS:
3.8513
순현금흐름:
$1.05B
1주 성능:
+7.68%
1개월 성능:
+2.85%
6개월 성능:
+11.71%
1년 성능:
-0.24%
1일 변동 폭
$94.06
$97.60
1주일 범위
$87.87
$97.60
52주 변동 폭
$79.12
$108.29
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.75 | 17.81B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
107.27 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
346.60 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
86.88 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.06 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.68 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-23 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2026-02-20 | 개시 | William Blair | Mkt Perform |
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
UBS Upgrades Zimmer Biomet Holdings to Buy From Sell, Adjusts Price Target to $115 From $89 - marketscreener.com
UBS initiates Zimmer Biomet stock coverage with buy rating By Investing.com - Investing.com Australia
Q1 Surgical Equipment & ConsumablesDiversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks - Yahoo Finance
Zimmer Biomet Holdings Inc (ZBH) Cash Flow - TradingKey
ZBH|Zimmer Biomet Holdings Inc|Price:91.350|Chg%:+1.720 - TradingKey
Zimmer Biomet Holdings Inc (ZBH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zimmer Biomet stock holds on report metrics and market context - AD HOC NEWS
Zimmer Biomet Holdings Inc (ZBH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zimmer Biomet Holdings Inc (ZBH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zimmer Biomet Holdings, Inc. Revenue Breakdown – BX:ZIM - TradingView
Zimmer Biomet Holdings, Inc. Common StockAlan Armstrong Congressional Trade on Mar. 27, 2026 - Quiver Quantitative
Zimmer Biomet stock trades steady as hip and knee demand supports guidance - AD HOC NEWS
A3LRUM Bond Profile — Key Metrics - TradingView
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings, Inc. Revenue Breakdown – BMV:ZBH - TradingView
Zimmer Biomet stock trades steadily as procedure demand supports revenue growth - AD HOC NEWS
Zimmer Biomet Holdings Inc (ZBH) Valuation: PE, PB & Fair Value Analysis - TradingKey
US98956PAV4 Bond Profile — Key Metrics - TradingView
Zimmer Biomet sues former executive accused of stealing trade secrets, breach of contract - The Journal Gazette
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Zimmer Biomet (NYSE: ZBH) executive Desai Chintan files initial Form 3 - Stock Titan
Zimmer Biomet stock trades steadily as investors weigh recent margin gains and guidance - Ad-hoc-news.de
XS153277974 Bond Profile — Key Metrics - TradingView
Zimmer Biomet Holdings (ZBH) Could Be 9% Undervalued After Asia Pacific Leadership Change - Sahm
A1899U Bond Profile — Key Metrics - TradingView
CH147843075 Bond Profile — Key Metrics - TradingView
Earnings Preview: What To Expect From Zimmer Biomet’s Report - Yahoo Finance
Zimmer Biomet stock trades steadily as hip and knee implant demand supports earnings - Ad-hoc-news.de
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zimmer Biomet (ZBH) Proxy filing Summary - Quartr
Zimmer Biomet stock holds near its yearly range after Q1 2026 results - Ad-hoc-news.de
ZBH4966995 Bond Profile — Key Metrics - TradingView
A3L563 Bond Profile — Key Metrics - TradingView
Zimmer Biomet stock trades steadily as orthopedic demand supports earnings - ad-hoc-news.de
Q3 2025 Zimmer Biomet Holdings Inc Earnings Call Transcript - GuruFocus
XS287510616 Bond Profile — Key Metrics - TradingView
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet stock steadies as hip and knee demand supports outlook - Ad Hoc News
Form 144 ZIMMER BIOMET HOLDINGS For: 16 July By Investing.com - Investing.com Nigeria
Suketu Upadhyay (NYSE: ZBH) files Form 144 to sell 7,668 shares - Stock Titan
Zimmer Biomet names new Asia Pacific president - Yahoo Finance
ZBH6004608 Bond Profile — Key Metrics - TradingView
Zimmer Biomet stock reflects steady medtech positioning - Ad Hoc News
A2SADH Bond Profile — Key Metrics - TradingView
US98956PBB7 Bond Profile — Key Metrics - TradingView
ZBH6004609 Bond Profile — Key Metrics - TradingView
Ardent Capital Management, Inc.'s Zimmer Biomet Holdings Inc(ZBH) Holding History - GuruFocus
ZIMC Bond Profile — Key Metrics - TradingView
Will Zimmer Biomet’s New Asia Pacific Leader Reframe Its Robotics-Led Growth Story (ZBH)? - Yahoo Finance
Zimmer Biomet Names Chintan Desai President of Asia Pacific Regi - GuruFocus
US98956PAV40 Bond Profile — Key Metrics - TradingView
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.47%
자본화:
|
볼륨(24시간):